AzTrials
AzTrials

DizzinessNCT06010550

Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo

An observational study of Dizziness and Vertigo, run by Chiayi Christian Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to validate a machine learning model that stratifies the risk of stroke in patients who present to the emergency department with dizziness or vertigo. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Dizziness, Vertigo
What is being tested?
Magnetic resonance imaging
Type of treatment
Surgery or procedure
How many people
600 participants
Where
No sites listed yet
Study dates
1 Oct 2023to 31 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Subjects who visit the emergency department.

Who may be able to join

  • Presenting to the emergency department with dizziness or vertigo
  • Aged ≥ 20
  • Dizziness or vertigo lasting for at least 1 hour and < 7 days
  • Persistent dizziness or vertigo at the time of the examination at the emergency department

Who cannot join

  • Having 5 or more prior episodes similar in quality, intensity, and duration to the current symptoms, with at least one episode more than a year prior and one within the past year
  • Having frank stroke-like symptoms or signs, such as hemiparesis, facial asymmetry, dysarthria, dysphasia, ataxia, gaze palsy
  • Consciousness disturbance, Glasgow coma scale < 13
  • Severe dementia
  • Recent stroke within 3 months
  • Dizziness or vertigo thought to be the result of head injury, hypotension, medication/drug intoxication, hypoglycemia, electrolyte imbalance, anemia, hepatic encephalopathy, hydrocephalus, etc
Show all 9Show fewer
  • Concomitant head or neck trauma
  • Severe degenerative cervical spondylosis
  • Having contraindications to magnetic resonance imaging examination

Trial locations and contacts

No sites are listed yet.

Sheng-Feng Sung, MD, PhD contact

886-5-2765041 ext. 7284

sfsung@cych.org.tw

About this study

Official title: Validating a Clinical Decision Support Tool for Stratifying Stroke Risk in Patients Presenting With Dizziness to the Emergency Department

This study aims to validate a machine learning model that stratifies the risk of stroke in patients who present to the emergency department with dizziness or vertigo.

Read the detailed description

This is a cross-sectional, hospital-based study, with no randomization procedure. Over a 21-month period, approximately 600 subjects will be enrolled. The study will assess the risk of stroke in each patient using a machine-learning model. To detect ischemic or hemorrhagic stroke, each patient will undergo a non-contrast brain magnetic resonance imaging study. The predictive performance of the machine-learning model will be evaluated in terms of accuracy, precision, recall, F1 score, and area under the receiver operating characteristics curve.

Conditions
Dizziness, Vertigo
Being tested
Magnetic resonance imaging
Keywords
Dizzy, Vertigo, Stroke, Machine learning
Medical subject headings
Dizziness, Vertigo, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Magnetic resonance imagingRadiation

    Brain magnetic resonance imaging

Study groups in NCT06010550
Study groupRoleWhat they receive
Dizziness/vertigoPatients aged 20 or above, presenting to the emergency department with dizziness or vertigo.
Receives: Radiation: Magnetic resonance imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with stroke

    Number of participants with ischemic or hemorrhagic stroke confirmed by brain magnetic resonance imaging

    Measured: Between 24 hours and 14 days after the emergency department visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2023
  2. Study start1 Oct 2023 (estimated)
  3. Primary completion31 Jul 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06010550
Sponsor's protocol ID
IRB2023009
Status last verified
Aug 2023
First submitted
20 Aug 2023
Last updated
29 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Dizziness and Vertigo, run by Chiayi Christian Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sheng-Feng Sung, MD, PhD (886-5-2765041 ext. 7284, sfsung@cych.org.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with stroke (time frame: Between 24 hours and 14 days after the emergency department visit). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06010550 | AzTrials